众友健康

众友健康 (Gansu Zhongyou Health Pharmaceutical) operates one of the largest pharmacy chains in Northwest China, with over 800 stores across several provinces including Gansu, Shaanxi, Ningxia, Qinghai, and Xinjiang[1][2][3][4]. The company focuses on pharmaceutical retail but also engages in medicinal herb cultivation, pharmaceutical R&D and production (on a limited scale), logistics distribution, and e-commerce[2]. It has been recognized for rapid expansion through mergers and acquisitions since around 2015[1][3].

The company does not conduct clinical trials or have an internal drug development pipeline; its main business lies in the distribution and sale of pharmaceuticals rather than their discovery or development.

Its annual revenue was reported at approximately RMB 2.56 billion (~$350 million USD), with significant market share in Northwest China[1][3].

It received strategic investment from Tasly Holding Group (天士力控股集团) in September 2016 (RMB ¥500 million for less than a 10% stake)[3].

Known as the "Northwest King" of Chinese pharma retail due to its dominance in that region[3].

No information suggests it has been acquired or merged into another entity.

The founder/chairman is Feng Dexiang (冯德祥)[3].